Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Retraction Note

Retraction Note: MiR-200c/FUT4 axis prevents the proliferation of colon cancer cells by downregulating the Wnt/β-catenin pathway

Authors: Jinchun Cong, Jian Gong, Chuanjia Yang, Zhixiu Xia, Hong Zhang

Published in: BMC Cancer | Issue 1/2023

Login to get access

Excerpt

Retraction Note: BMC Cancer (2020) 21:2
Metadata
Title
Retraction Note: MiR-200c/FUT4 axis prevents the proliferation of colon cancer cells by downregulating the Wnt/β-catenin pathway
Authors
Jinchun Cong
Jian Gong
Chuanjia Yang
Zhixiu Xia
Hong Zhang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11471-4

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine